Factor Deficiencies in Pregnancy

Hematology/Oncology Clinics of North America

Volumn 25, Issue 2, 2011, Pages 359-378

  Pike, Gillian N ^a   Bolton Maggs, Paula H B ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Factor deficiencies; Hemorrhage; Obstetric; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; FIBRINOGEN; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9; TRANEXAMIC ACID; VITAMIN K GROUP;

AFIBRINOGENEMIA; AMNIOCENTESIS; BLEEDING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING FACTOR DEFICIENCY; BRAIN HEMORRHAGE; CHORION VILLUS SAMPLING; COMPRESSION GARMENT; CONCEPTION; CORDOCENTESIS; CRYOPRECIPITATE; DRUG HALF LIFE; DYSFIBRINOGENEMIA; DYSPROTHROMBINEMIA; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; HEMATOMA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HYDRATION; HYPOFIBRINOGENEMIA; HYPOPROTHROMBINEMIA; LABOR MANAGEMENT; MOBILIZATION; POSTPARTUM HEMORRHAGE; PREGNANCY; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; PUERPERIUM; REVIEW; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT PLANNING; UTERINE CERVIX DILATATION; VAGINAL DELIVERY; VITAMIN DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN K DEPENDENT CLOTTING FACTOR DEFICIENCY; VITAMIN SUPPLEMENTATION; WATER DEPRIVATION;

BLOOD COAGULATION DISORDERS, INHERITED; CONSANGUINITY; DELIVERY, OBSTETRIC; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; POSTPARTUM PERIOD; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 79953060224     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2011.01.007     Document Type: Review

References (120)

1. Bolton-Maggs P.H., Perry D.J., Chalmers E.A., et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004, 10(5):593-628.
2. Lee C.A., Chi C., Pavord S.R., et al. The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006, 12(4):301-336.
3. Kadir R., Chi C., Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia 2009, 15(5):990-1005.
4. Chi C., Lee C.A., Shiltagh N., et al. Pregnancy in carriers of haemophilia. Haemophilia 2008, 14(1):56-64.
5. Menache D. Congenital fibrinogen abnormalities. Ann N Y Acad Sci 1983, 408:121-130.
6. Acharya S.S., Dimichele D.M. Rare inherited disorders of fibrinogen. Haemophilia 2008, 14(6):1151-1158.
7. Peyvandi F., Asselta R., Mannucci P.M. Autosomal recessive deficiencies of coagulation factors. Rev Clin Exp Hematol 2001, 5(4):369-388.
8. Evron S., Anteby S.O., Brzezinsky A., et al. Congenital afibrinogenemia and recurrent early abortion: a case report. Eur J Obstet Gynecol Reprod Biol 1985, 19(5):307-311.
9. Kobayashi T., Kanayama N., Tokunaga N., et al. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000, 109(2):364-366.
10. Goodwin T.M. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv 1989, 44(3):157-161.
11. Ness P.M., Budzynski A.Z., Olexa S.A., et al. Congenital hypofibrinogenemia and recurrent placental abruption. Obstet Gynecol 1983, 61(4):519-523.
12. Mensah P.K., Oppenheimer C., Watson C., et al. Congenital afibrinogenaemia in pregnancy. Haemophilia 2011, 17(1):167-168.
13. Liedholm P., Astedt B. Fibrinolytic activity of the rat ovum, appearance during tubal passage and disappearance at implantation. Int J Fertil 1975, 20(1):24-26.
14. Beller F.K., Ebert C. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol 1982, 13(3):177-197.
15. Fletcher A.P., Alkjaersig N.K., Burstein R. The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function. Am J Obstet Gynecol 1979, 134(7):743-751.
16. Trehan A.K., Fergusson I.L. Congenital afibrinogenaemia and successful pregnancy outcome. Case report. Br J Obstet Gynaecol 1991, 98(7):722-724.
17. Kobayashi T., Asahina T., Maehara K., et al. Congenital afibrinogenemia with successful delivery. Gynecol Obstet Invest 1996, 42(1):66-69.
18. Inamoto Y., Terao T. First report of case of congenital afibrinogenemia with successful delivery. Am J Obstet Gynecol 1985, 153(7):803-804.
19. Grech H., Majumdar G., Lawrie A.S., et al. Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature. Br J Haematol 1991, 78(4):571-572.
20. Matsuno K., Mori K., Amikawa H. A case of congenital afibrinogenemia with abortion, intracranial hemorrhage and peritonitis. Jpn J Clin Hematol 1977, 18:1438.
21. Dube B., Agarwal S.P., Gupta M.M., et al. Congenital deficiency of fibrinogen in two sisters. A clinical and haematological study. Acta Haematol 1970, 43(2):120-127.
22. Aygoren-Pursun E., Martinez Saguer I., Rusicke E., et al. Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions. Am J Hematol 2007, 82(4):317-320.
23. Brenner B., Kuperman A.A., Watzka M., et al. Vitamin K-dependent coagulation factors deficiency. Semin Thromb Hemost 2009, 35:439-446.
24. Roque H., Stephenson C., Lee M.J., et al. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies. Am J Hematol 2004, 76(3):267-270.
25. Haverkate F., Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995, 73(1):151-161.
26. Edwards R.Z., Rijhsinghani A. Dysfibrinogenemia and placental abruption. Obstet Gynecol 2000, 95(6 Pt 2):1043.
27. Peyvandi F., Mannucci P.M. Rare coagulation disorders. Thromb Haemost 1999, 82:1207-1214.
28. Girolami A., Scarano L., Saggiorato G., et al. Congenital deficiencies and abnormalities of prothrombin. Blood Coagul Fibrinolysis 1998, 9(7):557-569.
29. Sun W.Y., Witte D.P., Degen J.L., et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A 1998, 95(13):7597-7602.
30. Catanzarite V.A., Novotny W.F., Cousins L.M., et al. Pregnancies in a patient with congenital absence of prothrombin activity: case report. Am J Perinatol 1997, 14(3):135-138.
31. United Kingdom Haemophilia Centre Doctors' Organisation Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003, 9(1):1-23.
32. Mannucci P.M., Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood 2004, 104(5):1243-1252.
33. Asselta R., Peyvandi F. Factor V deficiency. Semin Thromb Hemost 2009, 35(4):382-389.
34. Kalafatis M. Coagulation factor V: a plethora of anticoagulant molecules. Curr Opin Hematol 2005, 12(2):141-148.
35. Castoldi E., Lunghi B., Mingozzi F., et al. A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the Italian population. Haematologica 2001, 86(6):629-633.
36. Girolami A., Scandellari R., Lombardi A.M., et al. Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature. Haemophilia 2005, 11(1):26-30.
37. Noia G., De Carolis S., De Stefano V., et al. Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature. Acta Obstet Gynecol Scand 1997, 76(9):890-892.
38. O'Donnell J.S. Severe factor V deficiency and pregnancy - a role for solvent-detergent plasma?. Haemophilia 2005, 11(4):422-423.
39. Bhavnani M., Evans D.I. Carriers of factor VII deficiency are not always asymptomatic. Clin Lab Haematol 1984, 6(4):363-368.
40. Castoldi E., Govers-Riemslag J.W., Pinotti M., et al. Coinheritance of factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation. Blood 2003, 102(12):4014-4020.
41. Kario K., Narita N., Matsuo T., et al. Genetic determinants of plasma factor VII activity in the Japanese. Thromb Haemost 1995, 73(4):617-622.
42. Giansily-Blaizot M., Biron-Andreani C., Aguilar-Martinez P., et al. Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding. Br J Haematol 2002, 117(1):172-175.
43. Robertson L.E., Wasserstrum N., Banez E., et al. Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate. Am J Hematol 1992, 40(1):38-41.
44. Fadel H.E., Krauss J.S. Factor VII deficiency and pregnancy. Obstet Gynecol 1989, 73(3 Pt 2):453-454.
45. Dalaker K., Prydz H. The coagulation factor VII in pregnancy. Br J Haematol 1984, 56:233-241.
46. Eskandari N., Feldman N., Greenspoon J.S. Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol 2002, 99(5 Pt 2):935-937.
47. Kulkarni A.A., Lee C.A., Kadir R.A. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006, 12(4):413-416.
48. Pehlivanov B., Milchev N., Kroumov G. Factor VII deficiency and its treatment in delivery with recombinant factor VII. Eur J Obstet Gynecol Reprod Biol 2004, 116(2):237-238.
49. Muleo G., Santoro R., Iannaccaro P.G., et al. The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies. Blood Coagul Fibrinolysis 1998, 9(4):389-390.
50. Jimenez-Yuste V., Villar A., Morado M., et al. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia 2000, 6(5):588-590.
51. Mannucci P.M., Tuddenham E.G. The hemophilias-from royal genes to gene therapy. N Engl J Med 2001, 344(23):1773-1779.
52. Lyon M.F. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 1962, 14:135-148.
53. Lusher J.M., McMillan C.W. Severe factor VIII and factor IX deficiency in females. Am J Med 1978, 65(4):637-648.
54. Greer I.A., Lowe G.D., Walker J.J., et al. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991, 98(9):909-918.
55. Knol H.M., Voskuilen M.A., Holterman F., et al. Reproductive choices and obstetrical experience in Dutch carriers of haemophilia A and B. Haemophilia 2010, [Epub ahead of print]. DOI:10.1111/j.1365-2516.2010.02351.x.
56. Kadir R.A., Economides D.L., Braithwaite J., et al. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol 1997, 104(7):803-810.
57. Santacroce R., Vecchione G., Tomaiyolo M., et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006, 12:417-422.
58. Ljung R., Lindgren A.C., Petrini P., et al. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994, 83(6):609-611.
59. El-Refaey H., Rodeck C. Post-partum haemorrhage: definitions, medical and surgical management. A time for change. Br Med Bull 2003, 67:205-217.
60. Hoveyda F., MacKenzie I.Z. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG 2001, 108(9):927-930.
61. Kulkarni R., Lusher J.M. Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol 1999, 21(4):289-295.
62. Uprichard J., Perry D.J. Factor X deficiency. Blood Rev 2002, 16(2):97-110.
63. Graham J., Barrow E.M., Hougie C. Stuart clotting defect. II. Genetic aspects of a 'new' hemorrhagic state. J Clin Invest 1957, 36(3):497-503.
64. Menegatti M., Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009, 35(4):407-415.
65. Peyvandi F., Mannucci P.M., Lak M., et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998, 102(2):626-628.
66. Brown D.L., Kouides P.A. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008, 14(6):1176-1182.
67. Knight R.D., Barr C.F., Alving B.M. Replacement therapy for congenital factor X deficiency. Transfusion 1985, 25(1):78-80.
68. Condie R.G. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol 1976, 83(8):636-639.
69. Mamopoulos A., Vakalopoulou S., Lefkou E., et al. Pregnancy in a patient with severe factor X deficiency. Haemophilia 2009, 15(6):1351-1353.
70. Arai S. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi 2001, 12(1):1-7. [in Japanese].
71. Beksac M.S., Atak Z., Ozlu T. Severe factor X deficiency in a twin pregnancy. Arch Gynecol Obstet 2010, 281:151-152.
72. van Veen J.J., Hampton K.K., Maclean R., et al. Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy. Blood Transfus 2007, 5(4):204-209.
73. Chiossi G., Spero J.A., Esaka E.J., et al. Plasma exchange in a case of severe factor X deficiency in pregnancy: critical review of the literature. Am J Perinatol 2008, 25(3):189-192.
74. Girolami A., Lazzarin M., Scarpa R., et al. Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family. Blood 1971, 37(5):534-541.
75. de Sousa C., Clark T., Bradshaw A. Antenatally diagnosed subdural haemorrhage in congenital factor X deficiency. Arch Dis Child 1988, 63(10 Spec No):1168-1170.
76. Konje J.C., Murphy P., de Chazal R., et al. Severe factor X deficiency and successful pregnancy. Br J Obstet Gynaecol 1994, 101(10):910-911.
77. Larrain C. Rev Med Chil 1994, 122(10):1178-1183. [in Spanish].
78. Kumar M., Mehta P. Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol 1994, 46(3):241-244.
79. Bofill J.A., Young R.A., Perry K.G. Successful pregnancy in a woman with severe factor X deficiency. Obstet Gynecol 1996, 88(4 Pt 2):723.
80. Rezig K., Diar N., Benabidallah D., et al. Ann Fr Anesth Reanim 2002, 21(6):521-524. [in French].
81. Romagnolo C., Burati S., Ciaffoni S., et al. Severe factor X deficiency in pregnancy: case report and review of the literature. Haemophilia 2004, 10(5):665-668.
82. Asakai R., Davie E.W., Chung D.W. Organization of the gene for human factor XI. Biochemistry 1987, 26(23):7221-7228.
83. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978, 51(6):1223-1228.
84. Peyvandi F., Lak M., Mannucci P.M. Factor XI deficiency in Iranians: its clinical manifestations in comparison with those of classic hemophilia. Haematologica 2002, 87(5):512-514.
85. Rapaport S.I., Proctor R.R., Patch M.J., et al. The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood 1961, 18:149-165.
86. Leiba H., Ramot B., Many A. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965, 11(6):654-665.
87. Bolton-Maggs P.H., Young Wan-Yin B., McCraw A.H., et al. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988, 69(4):521-528.
88. Gomez K., Bolton-Maggs P. Factor XI deficiency. Haemophilia 2008, 14(6):1183-1189.
89. Bolton-Maggs P.H., Patterson D.A., Wensley R.T., et al. Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study. Thromb Haemost 1995, 73(2):194-202.
90. Ragni M.V., Sinha D., Seaman F., et al. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985, 65(3):719-724.
91. Kadir R.A., Lee C.A., Sabin C.A., et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998, 105(3):314-321.
92. Myers B., Pavord S., Kean L., et al. Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with factor XI deficiency. BJOG 2007, 114:643-646.
93. Chi C., Kulkarni A., Lee C.A., et al. The obstetric experience of women with factor XI deficiency. Acta Obstet Gynecol Scand 2009, 88:1095-1100.
94. Salomon O., Steinberg D.M., Tamarin I., et al. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005, 16:37-41.
95. Mannucci P.M., Bauer K.A., Santagostino E., et al. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood 1994, 84:1314-1319.
96. Bolton-Maggs P.H., Colvin B.T., Satchi B.T., et al. Thrombogenic potential of factor XI concentrate. Lancet 1994, 344(8924):748-749.
97. Bolton-Maggs P.H., Wensley R.T., Kernoff P.B., et al. Production and therapeutic use of a factor XI concentrate from plasma. Thromb Haemost 1992, 67(3):314-319.
98. Bern M.M., Sahud M., Zhukov O., et al. Treatment of factor XI inhibitor using recombinant activated factor VIIa. Haemophilia 2005, 11(1):20-25.
99. Lawler P., White B., Pye S., et al. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia 2002, 8(2):145-148.
100. Board P.G., Losowsky M.S., Miloszewski K.J. Factor XIII: inherited and acquired deficiency. Blood Rev 1993, 7(4):229-242.
101. Asahina T., Kobayashi T., Okada Y., et al. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000, 21(4):388-393.
102. Koseki-Kuno S., Yamakawa M., Dickneite G., et al. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003, 102(13):4410-4412.
103. Asahina T., Kobayashi T., Takeuchi K., et al. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007, 62:255-260.
104. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001, 86:57-65.
105. Kobayashi T., Terao T., Kojima T., et al. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990, 29:235-238.
106. Kobayashi T., Asahina T., Okada Y., et al. Studies on the localisation of adhesive proteins associated with the development of extravillous cytotrophoblast. Troph Res 1999, 13:35-53.
107. Burrows R.F., Ray J.G., Burrows E.A. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000, 55(2):103-108.
108. Fukue H., Arai M. Factor XIIIA subunit deficiency. Jpn J Thromb Hemost 2001, 12:66-73.
109. Giddings J.C., Seligsohn U., Bloom A.L. Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol 1977, 37(2):257-264.
110. Nichols W.C., Seligsohn U., Zivelin A., et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998, 93(1):61-70.
111. Zhang B., McGee B., Yamaoka J.S., et al. Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. Blood 2006, 107(5):1903-1907.
112. Spreafico M., Peyvandi F. Combined FV and FVIII deficiency. Haemophilia 2008, 14:1201-1208.
113. Rost S., Fregin A., Ivaskevicius V., et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004, 427(6974):537-541.
114. Brenner B., Sanchez-Vega B., Wu S.M., et al. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors. Blood 1998, 92(12):4554-4559.
115. Oldenburg J., von Brederlow B., Fregin A., et al. Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost 2000, 84(6):937-941.
116. McMahon M.J., James A.H. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 2001, 97(5 Pt 2):808-809.
117. Mousallem M., Spronk H.M., Sacy R., et al. Congenital combined deficiencies of all vitamin K-dependent coagulation factors. Thromb Haemost 2001, 86(5):1334-1336.
118. Johnson C.A., Chung K.S., McGrath K.M., et al. Characterization of a variant prothrombin in a patient congenitally deficient in factors II, VII, IX and X. Br J Haematol 1980, 44(3):461-469.
119. Vicente V., Maia R., Alberca I., et al. Congenital deficiency of vitamin K-dependent coagulation factors and protein C. Thromb Haemost 1984, 51(3):343-346.
120. Lindley C.M., Sawyer W.T., Macik B.G., et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994, 55(6):638-648.